journal article·2009-06-15

Cytocompatibility and hemocompatibility of a novel chitosan‐alginate gel system

M. Notara, C. A. Scotchford, D. M. Grant, N. Weston, G. A. F. Roberts

Publisher page

Abstract

Abstract Two chitosan‐alginate gel systems in the form of membranes were produced and evaluated. The first membrane was produced by a novel gel system formed after blending N‐(methylsulfonic acid) chitosan with ammonium alginate (CAG1) and the second was an N‐(methylsulfonic acid) chitosan‐sodium alginate blend cross‐linked with glutaraldehyde and calcium chloride (CAG2). The cytocompatibility and hemocompatibility of the gels were examined by assessing the cell viability of 3T3 Swiss mouse fibroblasts, whole blood hemolysis, and platelet activation. Cell viability was not significantly different by exposure to these gels compared to the controls. Both gel types had minimal effect on hemolysis of whole heparinized rabbit blood after 1‐h exposure. Further platelet activation by the surfaces was also minimal. These results indicate that these novel gels merit further investigation for blood contact applications. © 2008 Wiley Periodicals, Inc. J Biomed Mater Res, 2009
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Polymer Surface Interaction Studies · Platelet Disorders and Treatments · Hemostasis and retained surgical items

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (27)

Show source-provided references
1. 10.1016/S0378-5173(98)00378-010.1016/S0378-5173(98)00378-0 ↗
2. 10.1002/jgm.32710.1002/jgm.327 ↗
3. 10.1016/j.joca.2006.06.01510.1016/j.joca.2006.06.015 ↗
4. 10.1016/j.biomaterials.2003.07.00410.1016/j.biomaterials.2003.07.004 ↗
5. RobertsG AndrewF. Chitosan condensation products their preparation and their uses.2001. European patent: EP1250359.10.1016/S0958-2118(01)80161-0 ↗
6. Roberts G · 2004 · 430
7. 10.1002/jbm.1014510.1002/jbm.10145 ↗
8. 10.1111/j.1540-8191.1992.tb00778.x10.1111/j.1540-8191.1992.tb00778.x ↗
9. A novel chitosan‐based gel system
10. 10.3109/0953710940900644010.3109/09537109409006440 ↗
11. Invitro vs exvivo platelet deposition on polymer surfaces
12. 10.1177/088532820301700400510.1177/0885328203017004005 ↗
13. 10.1016/S0142-9612(01)00009-610.1016/S0142-9612(01)00009-6 ↗
14. 10.1016/S0049-3848(00)00255-310.1016/S0049-3848(00)00255-3 ↗
15. 10.1016/j.cis.2004.02.00110.1016/j.cis.2004.02.001 ↗
16. 10.1002/jbm.a.2011010.1002/jbm.a.20110 ↗
17. 10.1046/j.1525-1594.2003.07275.x10.1046/j.1525-1594.2003.07275.x ↗
18. 10.1002/1097-4636(200011)52:2<285::AID-JBM7>3.0.CO;2-G10.1002/1097-4636(200011)52:2<285::AID-JBM7>3.0.CO;2-G ↗
19. 10.1163/15685620332259973410.1163/156856203322599734 ↗
20. Khor E · 2001
21. 10.1016/S0939-6411(01)00191-610.1016/S0939-6411(01)00191-6 ↗
22. 10.1016/0304-4165(83)90192-710.1016/0304-4165(83)90192-7 ↗
23. 10.1097/00007890-199311000-0003010.1097/00007890-199311000-00030 ↗
24. 10.3109/1073119790911938710.3109/10731197909119387 ↗
25. Hoffbrand AV · 2002
26. 10.1002/(SICI)1099-1581(199608)7:8<675::AID-PAT609>3.0.CO;2-U10.1002/(SICI)1099-1581(199608)7:8<675::AID-PAT609>3.0.CO;2-U ↗
27. 10.1016/j.biomaterials.2006.08.00510.1016/j.biomaterials.2006.08.005 ↗